Research & Development
Pathology & AI
Biosensors: Page 2
Saliva-based graphene sensor shows high sensitivity in preliminary studies
IdentifySensors Biologics is developing saliva-based digital graphene nanosensor technology that it believes can be more sensitive than PCR in detecting COVID-19.
December 12, 2022
Measuring fitness, disease risk without strenuous testing in the lab
University of Cambridge researchers used a deep neural network to process and extract information from raw sensor data and to predict VO2max, an indicator of fitness and marker of heart disease and mortality risk.
December 1, 2022
Chest publication suggests potential for MagArray blood test to stratify lung cancer risk
Its Knodule ID test is a multianalyte assay with algorithmic analysis comprising seven protein biomarkers and six clinical factors.
November 21, 2022
Glympse to present data on the detection of hepatocellular carcinoma with biosensor platform
In combination, the Glympse assay and a blood biomarker test demonstrated an area under the curve (AUC) of 0.90 in differentiating HCC and cirrhosis patients.
October 25, 2022
ProtonDx secures £365K grant to develop point-of-care tests for porcine lung disease
ProtonDx said this week it has been awarded a £365,000 ($404,238 U.S.) grant from two organizations to develop point-of-care tests for porcine lung diseases.
September 29, 2022
Epicore announces partnership with 3M and Innovize to scale portfolio of wearable hydration solutions
Wearable solutions developer Epicore Biosystems on Thursday announced a partnership with 3M’s Health Care Business and Innovize to scale the development of its sweat-sensing wearable technology.
September 29, 2022
Week in Review: Siemens, Roche, Qiagen launch new testing products; glucose test market to reach $20.4B this year; biosensor developer Know Labs goes public; more
Dear LabPulse.com member,
September 21, 2022
Biosensor developer Know Labs goes public on the NYSE
After the close of trading Thursday, the company announced the pricing of an underwritten public offering of 3.6 million shares at $2.00 per share; it granted to the underwriter a 45-day option to purchase up to 540,000 additional shares at the same price.
September 15, 2022
NanoDx, SkyWater launch nano biosensor
The companies said that as a result of the development, NanoDx is ready to prepare and submit the product for review by the U.S. Food and Drug Administration (FDA) with the aim of eventually commercializing a product based on the technology.
August 25, 2022
Monod Bio secures $25M in seed financing
Matrix Capital led the financing round; Global Health Investment, Cercano Management, the Washington Research Foundation, Boom Capital Ventures, Sahsen Ventures, and Pack Ventures also participated.
August 14, 2022
GBS study compares glucose levels in saliva, blood
The developer of a biosensor platform for point-of-care testing said it will now perform statistical analyses of the correlation of glucose levels among the sample types.
July 13, 2022
SD Biosensor, SJL Partners to acquire Meridian Bioscience
Under the terms of the agreement, shareholders of Cincinnati, OH-based Meridian Bioscience will receive $34 per share in cash, which represents a premium of 16% compared to the firm's one-month average price per share starting Thursday.
July 6, 2022
Page 2 of 3